UK markets closed

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.46-0.03 (-0.12%)
At close: 04:00PM EDT
24.46 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.15B
Enterprise value 1.17B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.37
Price/book (mrq)4.63
Enterprise value/revenue 6.30
Enterprise value/EBITDA -8.60

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 3-9.37%
S&P500 52-week change 322.36%
52-week high 335.56
52-week low 323.14
50-day moving average 326.50
200-day moving average 328.11

Share statistics

Avg vol (3-month) 3497.16k
Avg vol (10-day) 3386.73k
Shares outstanding 547.12M
Implied shares outstanding 647.12M
Float 835.19M
% held by insiders 12.24%
% held by institutions 1112.44%
Shares short (15 Apr 2024) 48.58M
Short ratio (15 Apr 2024) 414.47
Short % of float (15 Apr 2024) 421.19%
Short % of shares outstanding (15 Apr 2024) 418.20%
Shares short (prior month 15 Mar 2024) 48.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -87.68%
Operating margin (ttm)-46.85%

Management effectiveness

Return on assets (ttm)-13.65%
Return on equity (ttm)-83.65%

Income statement

Revenue (ttm)186.37M
Revenue per share (ttm)4.56
Quarterly revenue growth (yoy)149.20%
Gross profit (ttm)N/A
EBITDA -98.33M
Net income avi to common (ttm)-163.42M
Diluted EPS (ttm)-4.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)286.33M
Total cash per share (mrq)6.09
Total debt (mrq)308.14M
Total debt/equity (mrq)123.92%
Current ratio (mrq)4.45
Book value per share (mrq)5.32

Cash flow statement

Operating cash flow (ttm)-70.94M
Levered free cash flow (ttm)-90.73M